New drug leads for resistant visceral leishmaniasis

Ended Project Grant Awarded Last action

Award ID
R21AI146729
Recipient
Awarding agency
Obligated
$1,118,317

Award facts

Assistance listing
93.855 Allergy and Infectious Diseases Research
Completion date
Originally
Funding
  • $849,289.63 Federal
  • $269,027.00 Non-federal
Place of performance
Birmingham, AL 35205, USA

Award details come from USAspending.gov.

Transactions

Action Federal Non-federal Date
Amendment -$7,709 $0
Amendment $269,027 $0
Amendment New drug leads for resistant visceral leishmaniasis - leishmaniasis is a major global health problem with more than 12 million confirmed cases worldwide,… $269,027 $269,027
Original award $318,945 $0

Quick answers

Who received award R21AI146729?

R21AI146729 was awarded to Southern Research Institute by National Institute of Allergy and Infectious Diseases (National Institutes of Health) on June 11, 2020.

How much is award R21AI146729 worth?

$1,118,317 has been obligated on R21AI146729: $849,290 in federal funding and $269,027 in non-federal funding.

On GovTribe

See this award's full record

  • Every transaction and subaward
  • The recipient's other awards and teaming partners
  • Similar grant awards
  • Ask GovTribe AI about this award